Evidence map›Paper›PMID 41041556›Full record

ArticleResearch square2025

Evaluation of a Rapid Immunoassay for Molecular Subphenotype Classification in Pediatric Acute Cardiorespiratory Failure.

Colin J Sallee, Clove S Taylor, Matt S Zinter, Daniela Markovic, Michelle J Lim, Ana Costa-Monteiro, Ruth Cortado, Andreas Schwingshackl, Michael Agus, Michael Matthay and 1 more

Abstract readPreprint
In one paragraph

Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Colin J SalleeUniversity of California Los Angeles.
Clove S TaylorUniversity of California Los Angeles.
Matt S ZinterUniversity of California San Francisco.
Daniela MarkovicUniversity of California Los Angeles.
Michelle J LimUniversity of California Davis.
Ana Costa-MonteiroUniversity of California Los Angeles.
Ruth CortadoUniversity of California Los Angeles.
Andreas SchwingshacklUniversity of California Los Angeles.
Michael AgusBoston Children's Hospital, Harvard Medical School.
Michael MatthayUniversity of California San Francisco.
Anil SapruUCLA Pediatric Critical Care.

Funding

Coagulation and Fibrinolysis in Pediatric Insulin Titration TrialR01HL114484 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SAPRU, ANIL · 2012 to 2015
$1.6M
Targeted Genomic Analysis of Coagulation Pathways in Acute Lung InjuryK23HL085526 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SAPRU, ANIL · 2007 to 2011
$756k
NHLBI NIH HHS K23 HL085526NHLBI NIH HHS R01 HL114484
6 · The paper itself

Abstract

Molecular subphenotypes, identified through biomarker profiling independent of clinical diagnosis, have the potential to guide targeted therapeutics in critical care. We have previously published that intensive insulin management has subphenotype-specific beneficial effects among children with hyperglycemia accompanying cardiorespiratory failure. However, due to the operational aspects of biomarker assays, prospective real-time application of subphenotype-based strategies remains daunting. This study compared biomarker values measured via a rapid immunoassay requiring minimal handling to a conventional laboratory-based multiplex assay, assessed its ability to classify subphenotypes with a parsimonious classifier, and compared clinical outcomes between rapid immunoassay-based subphenotypes. This retrospective multicenter study included re-assaying plasma samples from 269 children with acute cardiorespiratory failure and hyperglycemia. Latent class analysis (LCA) was previously used to derive hyper-inflammatory and hypo-inflammatory classes. A parsimonious classifier was fit to LCA-derived subphenotypes and produced a model consisting of IL-6, IL-8, and sTNFR-1. We found that, despite the rapid immunoassay systematically overestimating biomarker values relative to the conventional assay, biomarkers were strongly correlated between platforms (Pearson

Indexed as

Biological HeterogeneityClinical TrialsMolecular SubphenotypingPrecision MedicineRapid Immunoassay

Identifiers

PMID41041556
PMCPMC12486067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.